Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[How to use Japanese guidelines for the treatment of multiple sclerosis].
Cinnamon Ameliorates Experimental Allergic Encephalomyelitis in Mice via Regulatory T Cells: Implications for Multiple Sclerosis Therapy.
Role of IL-16 in CD4(+) T cell-mediated regulation of relapsing multiple sclerosis.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Remyelination Therapy for Multiple Sclerosis.
Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: A case report and brief review of literature.
The induction of Treg cells by gut-indigenous Clostridium.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis.
[Charcot and his legacy to medicine].
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Detection of reduced interhemispheric cortical communication during task execution in multiple sclerosis patients using functional near-infrared spectroscopy.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Effect of stress on brain inflammation and multiple sclerosis.
Passive induction of experimental allergic encephalomyelitis.
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Evaluating cognitive rehabilitation in multiple sclerosis: on the bumpy road to establishing evidence.
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Pages
« first
‹ previous
…
254
255
256
257
258
259
260
261
262
…
next ›
last »